CLBCX
Price
$36.12
Change
+$0.03 (+0.08%)
Updated
Sep 20 closing price
PSQGX
Price
$18.16
Change
-$0.03 (-0.16%)
Updated
Sep 20 closing price
Ad is loading...

CLBCX vs PSQGX

Header iconCLBCX vs PSQGX Comparison
Open Charts CLBCX vs PSQGXBanner chart's image
American Funds American Balanced 529C
Price$36.12
Change+$0.03 (+0.08%)
VolumeN/A
CapitalizationN/A
Port Street Quality Growth Institutional
Price$18.16
Change-$0.03 (-0.16%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CLBCX vs PSQGX Comparison Chart
Loading...
VS
CLBCX vs. PSQGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a StrongBuy and PSQGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 236B vs. PSQGX (221M). CLBCX (1.52) and PSQGX (1.49) have matching dividends . CLBCX was incepted earlier than PSQGX: CLBCX (23 years) vs PSQGX (10 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. PSQGX (9.00). CLBCX has a lower initial minimum investment than PSQGX: CLBCX (250) vs PSQGX (2000). CLBCX annual gain was more profitable for investors over the last year : 23.45 vs. PSQGX (14.84). CLBCX (36.47) and PSQGX (34.82) have equivalent 5 years return.
CLBCXPSQGXCLBCX / PSQGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years10 years-
Gain YTD13.40412.168110%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets236B221M106,787%
Annual Yield % from dividends1.521.49102%
Returns for 1 year23.4514.84158%
Returns for 3 years13.7211.23122%
Returns for 5 years36.4734.82105%
Returns for 10 years54.7284.7965%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTSH75.630.43
+0.57%
Cognizant Technology Solutions Corp
DNLI30.92-0.13
-0.42%
Denali Therapeutics
ANTX1.05-0.03
-2.78%
AN2 Therapeutics
MXL13.93-0.49
-3.40%
MaxLinear
MVST0.29-0.02
-6.13%
Microvast Holdings